He kept saying March, so I'm going with March (this March).
But, what has me even more stumped is why would you sell now when we are so close to a result - and the presentation is the most firm indication of an end in sight for trial results (I know I've been saying this for ages now).
Positive result would have to see SP as a minimum back to 52 week highs (+8 c) ? .... Then will be interesting to see if they can back it up quickly with a nutraceutical deal (Which I imagine is waiting on ASD trial results for an indication on safety).... And then it could be a one two catalyst for re rate.
Things are about to heat up (Or flop) that's for sure.
With all the preclinical indications, LOW THC, etc and his old presentation which was a when not if the phase I/II are positive this has to be the highest odds off success and upside potential Biotech play around. That's just me on the ramp again, and why I've got a bucket load of theses...
NTI Price at posting:
4.6¢ Sentiment: Buy Disclosure: Held
